Peter Goodhand

Executive Director, The Global Alliance for Genomics and Health

Peter Goodhand

Peter Goodhand is a leader in the global health sector as a senior executive and board member in the health research advancement community.

Goodhand played a key role in the creation of the global alliance to accelerate progress in genomic research and medicine and in June 2013, he was appointed acting Executive Director of the Alliance for its critical development phase.

Prior to this role, he was the President and CEO of the Canadian Cancer Society – Canada’s largest health charity. Before joining the charitable sector, Goodhand had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies such as American Cyanamid and Johnson & Johnson and as the founding Managing Director of the Health Technology Exchange (HTX).

He is currently Chair of the Board of HTX; Chair of the Steering Committee of the Occupational Cancer Research Center; Board Member, MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation); and works with the Institute of Corporate Directors to advance governance within the not-for -profit sector.

He served as board Chair and President of Canada’s Medical Device Industry association (MEDEC), chaired the Government of Canada’s Expert working group on the future of medical isotope production, and was a member of the Canadian delegation to the UN summit on non-communicable diseases.

Goodhand had a 12-year experience as a patient advocate, caregiver and navigator throughout his family’s battle with a rare cancer.